近二十年急性颈动脉支架内血栓证据综述
该系统综述与meta分析依据PRISMA检索近二十年文献,纳入29篇共60例急性颈动脉支架内血栓患者,汇总发生率、危险因素与早期处理。结果显示急诊手术、双联抗血小板治疗依从性差或抵抗、双分子层支架及重叠支架与风险升高相关,56.7%出现神经功能恶化。
要点
- 急诊及神经不稳定患者ACST发生率更高(5.6%–33%)。
- 抗血小板依从性差或抵抗是最常见报告的危险因素。
- 双分子层支架风险更高(45% vs 3.7%;P=.0001;OR 21.3)。
核心结论
- ACST在急诊及神经不稳定患者中发生率更高,抗血小板依从性差/抵抗、长狭窄病变、多枚支架及双分子层支架与风险增加相关。
研究设计与样本
- 系统综述与meta分析,按PRISMA推荐执行,最终纳入29篇文献共60例患者。
主要发现
- 急诊手术相关ACST发生率为5.6%至33%。
- 双分子层支架组ACST发生率45% vs 3.7%(P=.0001;OR 21.3)。
- 重叠支架作为补救与ACST风险相关(7.3% vs 0.002%)。
- 长狭窄病变长度22.9±6.83 mm vs 14.2±6.42 mm(P=.0034),支架长度3.8±0.4 cm vs 2.8±0.86 cm(P=.0055)。
临床怎么用
- 无症状ACST一致采用保守管理。
- 术中ACST最常用血管内治疗。
- 外科选项包括颈动脉内膜切除加支架取出(n=9),其中2例为血管内治疗失败后的补救。
局限性
- 需进一步研究以更好定义最佳管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Acute carotid stent thrombosis (ACST) occurring in the first hours after the procedure is an exceedingly rare complication of carotid artery stenting, but it is potentially devastating. This review aimed to evaluate current literature, identifying all reported cases during the last two decades, with the final purpose of reporting predictive factors and early management. METHODS: A systematic review and meta-analysis was conducted according to the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. RESULTS: A total of 464 potentially relevant articles were selected. After review of records at title and abstract level, 29 articles with 60 patients were included. Twelve studies reported on ACST incidence rate in their cohorts, ranging from 0.36% to as high as 33%. In considering etiology, antiplatelet noncompliance or resistance is the most frequently reported risk factor. Emergency procedures seemed to be associated with greater risk for ACST, reaching 5.6% to 33% incidence. Dual-layer stents were also associated with greater risk (45% vs 3.7%; P = .0001; odds ratio, 21.3). Use of an overlapping stent as a bailout procedure because of dissection, malposition, or long lesions was correlated with increased risk (7.3% vs 0.002%), as were long stenotic lesions (22.9 ± 6.83 mm vs 14.2 ± 6.42 mm; P = .0034) and stent length (3.8 ± 0.4 cm vs 2.8 ± 0.86 cm; P = .0055). ACST was associated with neurologic status deterioration in 56.7% of cases. Time to symptoms or ACST diagnosis had a median of 1.5 hours, with 30% occurring intraprocedurally. In asymptomatic ACST, conservative management was unanimous. Endovascular treatment was the most common approach to intraprocedural ACST. Surgical options included carotid endarterectomy with stent explantation (n = 9), which was also a bailout after failed endovascular treatment in two cases. CONCLUSIONS: ACST incidence is higher in emergent, neurologically unstable patients. Antiplatelet noncompliance, antiplatelet resistance, long stenotic lesions, use of more than one stent, and dual-layer stents are also associated with increased risk. The decision as to the best approach depends on whether ACST occurs intraprocedurally or afterward, the development of neurologic status deterioration, and the center's experience. However, additional studies must be undertaken to better define optimal management.
引用
- Coelho AP, Lobo M, Nogueira C, et al. Overview of evidence on risk factors and early management of acute carotid stent thrombosis during the last two decades. J Vasc Surg. 2019. PMID: 30798846. doi:10.1016/j.jvs.2018.09.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。